Telix Pharmaceuticals Ltd has released a press release.
Activities Report and Appendix 4C - June 2023 Quarter
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
Story so far
Earlier from Telix Pharmaceuticals
- Lightpoint Acquisition to Expand Telix Urologic Pipeline
- Phase II study for indication expansion of TLX250-CDx doses
- Annual General Meeting - Presentation
- Annual General Meeting - Chairman and CEO Addresses
- ZIRCON Data Presented at AUA Confirms Efficacy in 2cm Masses
Later from Telix Pharmaceuticals
- Q2 2023 Business Update to Accompany Quarterly Results
- First Patient Dosed in Phase 3 Illuccix China Study
- 1H 2023 Appendix 4D and Interim Report
- 1H 2023 Results Presentation
- 1H 2023 Results Release
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals